Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Reconciliation of net income (loss) to cash provided by operating activities:
Depreciation, amortization, and accretion	$ 118,747	$ 124,278	$ 117,010
Impairment of Long-Lived Assets to be Disposed of and Held-for-use	20,940	95,196	3,621
Impairment of goodwill	0	25,784	0
Provision (benefit) for deferred income taxes	188	(297)	(888)
Equity-based compensation expense	6,616	8,127	7,379
Provision for doubtful accounts	6,857	5,039	2,156
Loss on disposal of discontinued operations	0	7,500	34,072
Other Noncash Income (Expense)	5,252	4,782	8,695
Gain from insurance recoveries associated with damaged equipment	(643)	(1,771)	0
Debt exchange expenses	4,892	0	0
CCLP Series A Preferred Unit distributions and adjustments	0	(3,574)	(4,005)
Warrants fair value adjustment	(251)	(1,624)	(11,129)
Contingent consideration liability fair value adjustment	0	(1,000)	3,400
Noncontrolling interest associated with discontinued operations	(47,898)	(13,538)	(22,623)
Gain on sale of assets	(4,668)	(2,333)	(729)
Changes in operating assets and liabilities, net of assets acquired:
Accounts receivable	62,569	6,471	(5,512)
Inventories	16,983	(2,770)	(29,221)
Prepaid expenses and other current assets	1,672	579	(3,888)
Trade accounts payable and accrued expenses	(62,274)	(16,545)	5,463
Other	(1,035)	(4,258)	(3,608)
Net cash provided by operating activities	76,912	90,232	46,586
Investing activities:
Purchases of property, plant, and equipment, net	(29,386)	(108,273)	(141,931)
Acquisition of businesses, net of cash acquired	0	(12,024)	(49,630)
Proceeds from disposal of business	0	0	3,121
Proceeds from sale of property, plant, and equipment	36,168	12,885	1,138
Proceeds from insurance recoveries associated with damaged equipment	643	1,771	0
Other investing activities	(1,387)	(801)	(1,344)
Net cash provided by (used in) investing activities	6,038	(106,442)	(188,646)
Financing activities:
Proceeds from long-term debt	477,647	282,590	767,887
Principal payments on long-term debt	(487,574)	(258,217)	(581,935)
Distributions to CCLP public unitholders	(1,244)	(1,233)	(19,224)
Redemptions of CCLP Series A Preferred	0	(28,049)	0
Proceeds from sale of common stock and exercise of stock options	0	0	251
Tax remittances on equity based compensation	(445)	(581)	(768)
Debt issuance costs and other financing activities	(6,013)	(435)	(11,217)
Net cash provided by (used in) financing activities	(17,629)	(5,925)	154,994
Effect of exchange rate changes on cash	805	(199)	779
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	66,126	(22,334)	13,713
Cash and cash equivalents and restricted cash at beginning of period	17,768	40,102	26,389
Cash and cash equivalents and restricted cash at end of period	83,894	17,768	40,102
Cash and cash equivalents at end of period associated with discontinued operations	(16,577)	(2,370)	(15,858)
Cash and cash equivalents and restricted cash at end of period associated with continuing operations	67,317	15,398	24,244
Supplemental cash flow information:
Interest paid	63,935	68,332	56,261
Taxes paid (refunded)	5,633	7,274	4,680
Accrued capital expenditures	$ 1,573	$ 3,625	$ 1,561